0001262463-16-000782.txt : 20160105 0001262463-16-000782.hdr.sgml : 20160105 20160105104338 ACCESSION NUMBER: 0001262463-16-000782 CONFORMED SUBMISSION TYPE: SC 13D/A PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20160105 DATE AS OF CHANGE: 20160105 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: MARIPOSA HEALTH, INC. CENTRAL INDEX KEY: 0001612253 STANDARD INDUSTRIAL CLASSIFICATION: BLANK CHECKS [6770] IRS NUMBER: 471201309 STATE OF INCORPORATION: DE FISCAL YEAR END: 0630 FILING VALUES: FORM TYPE: SC 13D/A SEC ACT: 1934 Act SEC FILE NUMBER: 005-89230 FILM NUMBER: 161320495 BUSINESS ADDRESS: STREET 1: 6803, THE CENTER 99 QUEENS ROAD CITY: HONG KONG STATE: K3 ZIP: 6803 BUSINESS PHONE: 85267713527 MAIL ADDRESS: STREET 1: 6803, THE CENTER 99 QUEENS ROAD CITY: HONG KONG STATE: K3 ZIP: 6803 FORMER COMPANY: FORMER CONFORMED NAME: ANDES 2 INC. DATE OF NAME CHANGE: 20140630 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: Chiang Richard CENTRAL INDEX KEY: 0001520631 FILING VALUES: FORM TYPE: SC 13D/A MAIL ADDRESS: STREET 1: 460 BRANNAN STREET SUITE 78064 CITY: SAN FRANCISCO STATE: CA ZIP: 94107 SC 13D/A 1 andes2sch13da.htm SC 13D/A

 

UNITED STATES 

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

SCHEDULE 13D/A

(Amendment No. 1)

 

Under The Securities Exchange Act of 1934

 
Mariposa Health Inc.
F/K/A ANDES 2 Inc.

(Name of Issuer)

 

Common Stock, $0.0001 Par Value Per Share

(Title of Class of Securities)

 

Applied For  

(CUSIP Number)

 

Richard Chiang

460 Brannan Street, Suite 78064

San Francisco, CA 94107

Telephone: (415) 713 6957

Email: rchiang8@gmail.com

 

(Name, Address and Telephone Number of Person

Authorized to Receive Notices and Communications)

  

December 8, 2014

(Date Of Event Which Requires Filing Of This Statement)

 

If the filing person has previously filed a statement on Schedule 13G to report the acquisition which is the subject of this Schedule 13D, and is filing this schedule because of Rule 13d-1(e), (f) or (g), check the following box o.

 

SCHEDULE 13D

 

(1)

NAMES OF REPORTING PERSONS. S.S. OR I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY):

Richard Chiang

 

(2) CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS)
  (a) o  
  (b) o  
         

 

(3) SEC USE ONLY

 

1 
 

 

(4) SOURCE OF FUNDS (SEE INSTRUCTIONS)

 

N/A

 

(5) CHECK IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(D) OR 2(E) o

 

 

(6) CITIZENSHIP OR PLACE OF ORGANIZATION

 

United States

 

NUMBER OF SHARES
BENEFICIALLY OWNED BY
EACH REPORTING PERSON
WITH

 

 (7) SOLE VOTING POWER

 

0

 

(8) SHARED VOTING POWER

 

0

 

(9) SOLE DISPOSITIVE POWER

 

0

 

(10) SHARED DISPOSITIVE POWER

 

0

 

(11) AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

 

0

 

(12) CHECK IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES o

 

 

(13) PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)

 

0

 

(14) TYPE OF REPORTING PERSON

 

IN

 

2 
 

 

ITEM 1. SECURITY AND ISSUER.

 

 

The security upon which this report is based is the common stock, par value $0.0001 per share, of Mariposa Health Inc., F/K/A ANDES 2 Inc. a Delaware corporation, with its principal place of business located at 6803 THE CENTER, 99 QUEENS ROAD, CENTRAL, HONG KONG.

 

 

ITEM 2. IDENTITY AND BACKGROUND.

 

(a) Name: Richard Chiang

(b) Address: 460 Brannan Street, Suite 78064 San Francisco, CA 94107

(c) Business consultant and private investor

(d) None.

(e) None.

(f) Citizenship: USA

 

ITEM 3. SOURCE AND AMOUNT OF FUNDS OR OTHER CONSIDERATION. 

 

The Reporting person Richard Chiang sold 10,000,000 shares of the Issuer in a private transaction to Expert Capital Investments Limited and received a sum of $40,000. After the sale, Mr. Chiang owns no shares of the Issuer's Common Stock.

 

ITEM 4. PURPOSE OF TRANSACTION.

 

The purpose of the transaction was for a change in control of the Issuer, based on a private sale of 10,000,000 shares of common stock of the Issuer by Reporting Person Richard Chiang to Expert Capital Investments Limited. The transaction closed on December 8, 2014.

 

On December 8, 2014, following the execution of the SPA and in accordance with its terms, Richard Chiang resigned as the sole Director of the Company's Board of Directors and Expert Capital Investments Limited elected Curtis Riley to be the sole Director of the Company's Board of Directors. Immediately following the election of Mr. Riley as the Director, Mr. Riley, acting as the sole Director of the Company, appointed himself as Chairman of the Board of Directors, President, Chief Financial Officer and Secretary

 

ITEM 5. INTEREST IN SECURITIES OF THE ISSUER.


Richard Chiang beneficially owns no shares of the Issuer's Common Stock.

 

 

ITEM 6. CONTRACTS, ARRANGEMENTS, UNDERSTANDINGS OR RELATIONSHIPS WITH RESPECT TO SECURITIES OF THE ISSUER.

 

Other than as described in this Schedule 13D/A, the Reporting Person has no contracts, arrangements, understandings or relationships with any other person with respect to any securities of the Issuer.

 

ITEM 7. MATERIAL TO BE FILED AS EXHIBITS.

 

None. The Registrant filed a Current Report on Form 8-K December 9, 2014 as exhibit 10.1.

  

3 
 

 

SIGNATURE

 

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

 

 

Date: January 4, 2016  

 

Signature:

 

/s/ Richard Chiang

Richard Chiang

 

 

 

 

4